Document is current
Any future updates will be listed below
-
Authors
Bouras, Marwan https://orcid.org/0000-0002-8335-5741
Tessier, Philippe
Poulain, Cécile
Schirr-Bonnans, Solène
Roquilly, Antoine
-
Funding
Funding for this research was provided by:
Horizon 2020 Framework Programme (No 847782)
- License Information
-
More Information
Article History
Received: 31 July 2024
Accepted: 2 October 2024
First Online: 11 October 2024
Declarations
:
: The Ethics Committee of Ouest II Angers (France) approved the study protocol in March 2021. This trial complied with the Declaration of Helsinki and was registered in March 2021 (number ClinicalTrial.gov NCT04793568). The patient’s legal surrogate provided written informed consent for participation.
: Informed consent was obtained from all patients or the patient’s legal representative.
: AR reports receiving grants and consulting fees from Merck and bioMerieux. Other authors declare that they have no conflicts of interest involving the work under consideration for publication. No compensation was received for this study.
